Oxygen (placebo) Clinical Trials
2 recruitingDrug
Phase 22Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Bernardino Clavo, MD, PhD42 enrolled1 locationNCT06799351
Recruiting
Phase 2Phase 3
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
Bernardino Clavo, MD, PhD42 enrolled1 locationNCT06706544